Monday , June 27 2022
Home / Tag Archives: gilead sciences stock

Tag Archives: gilead sciences stock

5 Coronavirus Stocks to Look Out For as COVID-19 Spread Continues

A few stocks, including some of the ones below, are being classified as COVID-19 stocks because of their potential to rise even as the pandemic worsens.Apart from the obvious health effects, the current coronavirus pandemic has already depleted financial markets all over the world. As the outbreak continues to spread and the world records a lot more confirmed cases, these economic effects are also going to continue. Many companies are already recording heavy losses and many of the world’s...

Read More »

At Least 20 Coronavirus Vaccines Are in Progress Globally, WHO Officials Confirm

As the search for COVID-19 vaccines intensifies, there are at least 20 coronavirus vaccines in the pipeline. However, Gilead Sciences (GILD) and Moderna (MRNA), the stocks of the leaders in the race, tumbled as the week came to the end.Coronavirus alias COVID-19 is the virus that has taken the humankind hostage for the past two months. It has led to most biotech companies to push beyond their limits in the search for a vaccine. As a result, the World Health Organization (WHO) officials...

Read More »

Coronavirus Vaccine Stock: Gilead Sciences or Moderna?

Let’s have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.In the race for a coronavirus vaccine, two horses battle for the lead, Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA). As a result, a lot of speculation on the booming of their stock prices has been in the mainstream media, since the outbreak of the deadly virus.Gilead Sciences is an American public biotech company...

Read More »

Gilead Sciences (GILD) Stock Is 2.53% Up, Its Remdesivir Used to Treat Coronavirus

Gilead Sciences (GILD) stock price has moved up at the news that its drug remdesivir is used to treat coronavirus patients on ‘compassionate’ grounds.Gilead Sciences Inc (NASDAQ: GILD) stock has made some gains after the confirmation of the use of one of its drugs on U.S. soil. Sources say that Remdesivir is being used to treat several patients who have coronavirus. The drug is not approved by the U.S. Food and Drug Administration (FDA). Certain rules allow for the use of such mediations on...

Read More »

Oil Companies Stock Down as Dow Jones Plummets 1,800 Points, Biotech Stocks Also Bleeding

Dow Jones has lost over 1,880 points due to a row of factors including Saudi’s oil price slash as well as the coronavirus that is quickly spreading. More bleeding is expected.All over the world, markets have been feeling terrible effects of the coronavirus COVID-19 outbreak. In recent times, the epidemic has caused stocks to plunge considerably, with a lot of companies seriously bleeding. Projections for the coronavirus have been quite pessimistic with forecasts that things will get worse....

Read More »

New Evergreen Stocks Such as GILD, MRNA Could Emerge amid Coronavirus

Some new evergreen stocks could become a new choice for investors. Moderna (MRNA), Gilead Sciences (GILD) and Co-Diagnostics (CODX) are also expected to change the game for coronavirus.New evergreen stocks could emerge as a result of the coronavirus crisis. These stocks have won such a status as global markets have tanked following the outbreak of COVID-19. The gaps created by coronavirus has caused the global economy to come to a standstill. This has affected the businesses all over the...

Read More »

Coronavirus Vaccine: 5 BioTech Stocks to Buy as a Hedge against COVID-19 Threat

As major biotech companies try to create a proper coronavirus vaccine, the following stocks just might be strong enough to hedge against the current financial plunge.The coronavirus epidemic isn’t letting down as many people hope it would. Instead, the number of confirmed cases as well as the mortality rate, are on a steady rise. The number of countries affected by the virus is also increasing steadily with many more countries confirming new cases of infection. The situation is worrisome to...

Read More »

Gilead Sciences (GILD) Stock Surges after Launching Phase 3 Studies for Coronavirus Treatment

Gilead Sciences (GILD) stock surged and reached an all-time high after the company confirmed the launching of phase 3 studies of coronavirus treatment.Gilead Sciences Inc (NASDAQ: GILD), an American biotech company that specializes in researching, developing and commercializing drugs, has seen its stock surge after it announced the launching of phase 3 studies for naval coronavirus (COVID-19) treatment. The stock price broke a very critical resistant level at $68 to trade above $70.Amid the...

Read More »